Sinocare Medical: Intends to repurchase shares of 15-30 million yuan for employee incentives.

Sinocare Medical announced that the company plans to repurchase shares through centralized bidding trading, with a repurchase amount not less than 15 million yuan and not more than 30 million yuan, of which earmarked loans will not exceed 27 million yuan. The repurchase price will not exceed 35.10 yuan per share, with a term from March 13, 2026 to March 12, 2027. The repurchased shares are intended to be used for employee stock ownership plans or equity incentives, and if not implemented within the specified period, the shares not transferred will be cancelled. In addition, the company's directors, supervisors, senior management, and controlling shareholders have no plans to reduce their holdings in the next six months. This repurchase carries risks such as price, funding, and policy.